Safety, Tolerability and Pharmacokinetics of TPOXX When Administered Orally for 28 Days

NCT04971109 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

467

Enrollment

INDUSTRY

Sponsor class

Conditions

Smallpox

Interventions

DRUG: TPOXX
OTHER: TPOXX Placebo

Sponsor

SIGA Technologies

Collaborators

[object Object]